Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules

K Magalon1, M Le Grand2, B El Waly1

  • 1Aix Marseille Univ, CNRS, IBDM, Marseille, France.

Neuropharmacology
|September 14, 2016
PubMed

Insights

Olesoxime promotes myelin repair in multiple sclerosis (MS) by enhancing oligodendrocyte maturation. This compound targets mitochondria, reducing reactive oxygen species (ROS) and promoting microtubule growth for myelin regeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Regenerative Medicine

Background:

  • Multiple sclerosis (MS) involves immune attacks, oligodendrocyte death, and demyelination, necessitating regenerative therapies.
  • Spontaneous myelin repair depends on endogenous oligodendrocyte progenitor cells (OPCs) differentiating at lesion sites.
  • Olesoxime, a cholesterol-like compound, shows potential in promoting OPC maturation and myelin regeneration.

Purpose of the Study:

  • To elucidate the mechanism of action of olesoxime in promoting oligodendrocyte maturation and myelin repair.
  • To investigate the role of mitochondrial function and reactive oxygen species (ROS) in olesoxime-mediated regeneration.
  • To identify cellular targets for developing new regenerative treatments for MS.

Main Methods:

  • Investigated olesoxime's effects on oligodendrocyte mitochondria and microtubule dynamics.
  • Assessed the impact of ROS scavengers on oligodendrocyte differentiation and mitochondrial morphology.
  • Utilized cell culture and rodent models to study myelin regeneration.

Main Results:

  • Olesoxime binds to oligodendrocyte mitochondria, inducing hyperfilamentation and reducing basal superoxide levels.
  • Mitochondrial hyperfilamentation correlates with increased End Binding Protein 1 (EB1) accumulation at microtubule growing ends.
  • ROS scavengers mimic olesoxime's effects, promoting differentiation, mitochondrial filamentation, and EB1-dependent microtubule polymerization.

Conclusions:

  • Olesoxime promotes oligodendrocyte maturation through mitochondrial hyperfilamentation and ROS modulation.
  • A bidirectional relationship exists between mitochondrial morphology and ROS levels in controlling oligodendrocyte differentiation.
  • These findings reveal novel cellular mechanisms for developing regenerative therapies for MS.